Supplementary data for "Biological heterogeneity in susceptibility to glucocorticoid induced bone loss: Short- and long-term hip BMD trajectories"

Combined Supplemental file containing the following 11 supplemental tables pertaining to the article: Biological heterogeneity in susceptibility to glucocorticoid induced bone loss: Short- and long-term hip BMD trajectories Supplemental Table 1) Glucocorticoid Prescriptions and Conversion Factors Supplemental Table 2) Anti-Osteoporotic Medication Codes Supplemental Table 3) Total DXA Scans in Study Cohort Supplemental Table 4) Table 1 ICD-10 Codes Supplemental Table 5) Proportional Hazards Assumption Test - Long-term Outcome Supplemental Table 6) Proportional Hazards Assumption Test - First Two Scans Only Supplemental Table 7) Age-Adjusted Hazard Ratios - Short-term Outcome Supplemental Table 8) Age-Adjusted Hazard Ratios - Long-term Outcome Supplemental Table 9) Dunn's Pairwise Comparison's (Bonferroni Adjusted) Supplemental Table 10) Competing Risk Analysis - Long-term outcome Supplemental Table 11) ICD-10 Codes Prior Initial GC Exposure - Short-term Tertiles

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-04
DOI
https://doi.org/10.5281/zenodo.14033066
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplementary data for "Biological heterogeneity in susceptibility to glucocorticoid induced bone loss: Short- and long-term hip BMD trajectories"

Zenodo (CERN European Organization for Nuclear Research)
Bone health and osteoporosis research
article

Supplementary data for "Biological heterogeneity in susceptibility to glucocorticoid induced bone loss: Short- and long-term hip BMD trajectories"

article en

Abstract

Combined Supplemental file containing the following 11 supplemental tables pertaining to the article: Biological heterogeneity in susceptibility to glucocorticoid induced bone loss: Short- and long-term hip BMD trajectories Supplemental Table 1) Glucocorticoid Prescriptions and Conversion Factors Supplemental Table 2) Anti-Osteoporotic Medication Codes Supplemental Table 3) Total DXA Scans in Study Cohort Supplemental Table 4) Table 1 ICD-10 Codes Supplemental Table 5) Proportional Hazards Assumption Test - Long-term Outcome Supplemental Table 6) Proportional Hazards Assumption Test - First Two Scans Only Supplemental Table 7) Age-Adjusted Hazard Ratios - Short-term Outcome Supplemental Table 8) Age-Adjusted Hazard Ratios - Long-term Outcome Supplemental Table 9) Dunn's Pairwise Comparison's (Bonferroni Adjusted) Supplemental Table 10) Competing Risk Analysis - Long-term outcome Supplemental Table 11) ICD-10 Codes Prior Initial GC Exposure - Short-term Tertiles

Zenodo (CERN European Organization for Nuclear Research)
University of Southern Denmark (DK)
Openalex Percentile: Top 61%
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Supplementary data for "Biological heterogeneity in susceptibility to glucocorticoid induced bone loss: Short- and long-term hip BMD trajectories" · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS